Stay updated on AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial

Sign up to get notified when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites (California, Illinois, Maryland) and updated the page to revision v3.3.3. The HHS Vulnerability Disclosure link was removed.
    Difference
    0.4%
    Check dated 2025-12-23T09:14:55.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.3.1 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-12-01T16:58:29.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page shows a minor version revision from v3.2.0 to v3.3.1, with no changes to study content, eligibility criteria, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:34:52.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice; no core study content or eligibility information was changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:41:19.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Minimal changes detected: only minor layout/UI updates with no impact on core study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:13:18.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and v3.2.0 release replaces v3.1.0; core content about status and transaction processing updated.
    Difference
    3%
    Check dated 2025-10-05T10:15:13.000Z thumbnail image

Stay in the know with updates to AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.